GAIN THERAPEUTICS, INC Current Assets
GAIN THERAPEUTICS, INC (GANX) had Current Assets of $14.97 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $14.97M.
- 2026-03-31: Assets, Current $18.22M.
- 2025-12-31: Assets, Current $22.24M.
- 2025-09-30: Assets, Current $10.52M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $14.97M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $18.22M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $22.24M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $10.52M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $9.31M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $11.15M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $11.60M 10-K · filed 2026-03-26 |
| 2024-09-30 | $13.74M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $18.54M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $13.86M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $17.78M 10-K · filed 2025-03-27 |
| 2023-09-30 | $13.24M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $17.31M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $19.32M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $21.09M 10-K · filed 2024-03-26 |
| 2022-09-30 | $24.35M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $25.83M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $36.39M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $37.72M 10-K · filed 2023-03-23 |
| 2021-09-30 | $41.55M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $44.34M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $47.38M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $8.99M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |